These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 3885017)

  • 1. Mutagenicity of pyrene in Salmonella.
    Matijasević Z; Zeiger E
    Mutat Res; 1985 Apr; 142(4):149-52. PubMed ID: 3885017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction with microsomal lipid as a major factor responsible for S9-mediated inhibition of 1,8-dinitropyrene mutagenicity.
    Shah AB; Combes RD; Rowland IR
    Mutat Res; 1991 Jul; 249(1):93-104. PubMed ID: 2067546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
    Araki A; Kamigaito N; Sasaki T; Matsushima T
    Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenium inhibition of benzo[a]pyrene, 3-methylcholanthrene, and 3-methylcholanthrylene mutagenicity in Salmonella typhimurium strains TA98 and TA100.
    Prasanna P; Jacobs MM; Yang SK
    Mutat Res; 1987 Feb; 190(2):101-5. PubMed ID: 3547113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic formation of pyrenequinones as enhancing agents of mutagenicity in Salmonella.
    Okamoto H; Yoshida D
    Cancer Lett; 1981 Jan; 11(3):215-20. PubMed ID: 7018664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and mutagenicity of 1-nitropyrene 4,5-oxide and 1-nitropyrene 9,10-oxide, microsomal metabolites of 1-nitropyrene.
    Fifer EK; Howard PC; Heflich RH; Beland FA
    Mutagenesis; 1986 Nov; 1(6):433-8. PubMed ID: 3331683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of mutagenicity of trioxane and dioxolane in Salmonella typhimurium.
    Kowalski Z; Spiechowicz E; Barański B
    Mutat Res; 1984 Jun; 136(3):169-71. PubMed ID: 6377055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity studies on fenitrothion in bacteria and mammalian cells.
    Hara M; Kogiso S; Yamada F; Kawamoto M; Yoshitake A; Miyamoto J
    Mutat Res; 1989 Jan; 222(1):53-61. PubMed ID: 2643032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of polycyclic aromatic hydrocarbons and quinones on Salmonella typhimurium TA97.
    Sakai M; Yoshida D; Mizusaki S
    Mutat Res; 1985; 156(1-2):61-7. PubMed ID: 3889628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutagenicity of mixtures of halogenated aliphatic hydrocarbons and polycyclic aromatic hydrocarbons in the Ames test with TA98 and TA100].
    Kevekordes S; Porzig J; Gebel T; Dunkelberg H
    Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):531-41. PubMed ID: 9531725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation and biotransformation of 1-nitropyrene in liver, lung and nasal tissue of rats.
    Bond JA
    Mutat Res; 1983 Dec; 124(3-4):315-24. PubMed ID: 6361542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propyldazine is mutagenic in Salmonella typhimurium and Escherichia coli: distinct specificity for strains TA1537 and TA97.
    Glatt H; Oesch F
    Teratog Carcinog Mutagen; 1985; 5(5):339-45. PubMed ID: 2867616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
    Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
    Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity of 2,6-dinitrotoluene and its metabolites, and their related compounds in Salmonella typhimurium.
    Sayama M; Mori M; Shirokawa T; Inoue M; Miyahara T; Kozuka H
    Mutat Res; 1989 Jul; 226(3):181-4. PubMed ID: 2664501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of the sunlight-exposed sample of pyrene in Salmonella typhimurium TA98.
    Takeda N; Teranishi K; Hamada K
    Bull Environ Contam Toxicol; 1984 Oct; 33(4):410-7. PubMed ID: 6386076
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo formation of mutagens by intraperitoneal administration of polycyclic aromatic hydrocarbons in animals during exposure to nitrogen dioxide.
    Miyanishi K; Kinouchi T; Kataoka K; Kanoh T; Ohnishi Y
    Carcinogenesis; 1996 Jul; 17(7):1483-90. PubMed ID: 8706253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity of dipyridyls and their methylated derivatives in Salmonella typhimurium/rat liver microsome system.
    Lin JK; Huang IH; Lee KW; Lin-Shiau SY
    Proc Natl Sci Counc Repub China B; 1989 Jan; 13(1):56-63. PubMed ID: 2657826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of automobile exhausts on mutagenicity of soils: contamination with, fractionation, separation, and preliminary identification of mutagens in the Salmonella/reversion assay and effects of solvent fractions on the sister-chromatid exchanges in human lymphocyte cultures and in the in vivo mouse bone marrow micronucleus assay.
    Wesp HF; Tang X; Edenharder R
    Mutat Res; 2000 Dec; 472(1-2):1-21. PubMed ID: 11113694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and detoxification of 1,8-dinitropyrene by mammalian hepatic fractions in the Salmonella mutagenicity assay.
    Shah AB; Combes RD; Rowland IR
    Mutagenesis; 1990 Jan; 5(1):45-9. PubMed ID: 2184311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Salmonella mutagenicity test: evaluation of 29 drug candidates.
    Aaron CS; Mazurek J; Zimmer DM; Swenson DH
    Mutat Res; 1989 Jun; 223(2):171-82. PubMed ID: 2662001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.